Literature DB >> 23265432

Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire.

Matthew S Parsons1, Robert J Center, Jean-Pierre Routy, Danielle Rouleau, Roger Leblanc, Mark A Wainberg, Cécile L Tremblay, Marcel D Zannou, Stephen J Kent, Michael D Grant, Nicole F Bernard.   

Abstract

A common idiotype of anti-HIV antibodies (Abs), designated as 1F7, was recently observed on anti-HIV broadly neutralizing Abs (BnAbs). The presence of the 1F7-idiotype on BnAbs suggests that continuous selection of 1F7-idiotypic Abs may allow these clones to achieve the somatic hypermutation necessary for broad neutralization. As the selection of type-specific BnAbs occurs in the setting of infections with a wide array of HIV subtypes, we investigated Abs from subjects infected with diverse subtypes for the selection of 1F7-idiotypic Abs. We observed the 1F7-idiotype on antiviral Abs in infections with various HIV subtypes. Furthermore, gp140-specific 1F7-idiotypic Abs recognized the gp140 antigens from several HIV subtypes. These results demonstrate that the 1F7-idiotype is a common characteristic of Abs from infections with diverse HIV subtypes, and suggests that early cross-reactivity of 1F7-idiotypic clones may act in conjunction with somatic hypermutation to produce BnAbs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23265432      PMCID: PMC3636582          DOI: 10.1089/aid.2012.0094

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  22 in total

1.  Stimulation of antiviral antibody response in SHIV-IIIB-infected macaques.

Authors:  S Muller; D H Margolin; G Min; D Lou; P Nara; M K Axthelm; H Kohler
Journal:  Scand J Immunol       Date:  2001-10       Impact factor: 3.487

2.  Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.

Authors:  Matthew S Parsons; Danielle Rouleau; Jean-Pierre Routy; Roger LeBlanc; Michael D Grant; Nicole F Bernard
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

3.  Mutation and selection during the secondary response to 2-phenyloxazolone.

Authors:  C Rada; S K Gupta; E Gherardi; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Authors:  Dennis R Burton; Ann J Hessell; Brandon F Keele; Per Johan Klasse; Thomas A Ketas; Brian Moldt; D Cameron Dunlop; Pascal Poignard; Lara A Doyle; Lisa Cavacini; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

Review 5.  Deceptive imprinting in the immune response against HIV-1.

Authors:  H Köhler; S Müller; P L Nara
Journal:  Immunol Today       Date:  1994-10

6.  An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.

Authors:  S Müller; D H Margolin; G Min
Journal:  Hybridoma       Date:  1997-02

7.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

8.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection.

Authors:  Douglas D Richman; Terri Wrin; Susan J Little; Christos J Petropoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

9.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

Authors:  Ronald S Veazey; Robin J Shattock; Melissa Pope; J Christian Kirijan; Jennifer Jones; Qinxue Hu; Tom Ketas; Preston A Marx; Per Johan Klasse; Dennis R Burton; John P Moore
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

10.  Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity.

Authors:  H Wang; S Müller; S Zolla-Pazner; H Köhler
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

View more
  2 in total

Review 1.  The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C Virus.

Authors:  Sybille Muller; Matthew S Parsons; Heinz Kohler; Michael Grant
Journal:  Front Oncol       Date:  2016-02-05       Impact factor: 6.244

Review 2.  Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases.

Authors:  Shing Yi Pan; Yvonne Cashinn Chia; Hui Rong Yee; Angelina Ying Fang Cheng; Clarice Evey Anjum; Yenny Kenisi; Mike Ks Chan; Michelle Bf Wong
Journal:  Future Sci OA       Date:  2020-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.